Detalles de la búsqueda
1.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Blood
; 142(17): 1438-1447, 2023 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37418685
2.
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.
Blood
; 140(17): 1907-1916, 2022 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789260
3.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632738
4.
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
Hematol Oncol
; 41(4): 655-662, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246287
5.
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
Hematol Oncol
; 40(1): 31-39, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34694649
6.
Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial.
Br J Haematol
; 194(2): 378-381, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002365
7.
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.
Blood
; 134(10): 798-801, 2019 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292118
8.
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis.
Ann Hematol
; 100(3): 653-659, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33495923
9.
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.
Ann Hematol
; 99(2): 331-341, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853703
10.
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study.
Eur J Haematol
; 104(6): 581-587, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32107795
11.
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
Int J Mol Sci
; 20(9)2019 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31064152
12.
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma.
Haematologica
; 108(6): 1671-1675, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36546422
13.
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma.
Blood
; 126(8): 950-6, 2015 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26089397
14.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28775121
15.
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line.
Am J Hematol
; 92(1): 82-87, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27770583
16.
Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL).
Br J Haematol
; 172(6): 879-88, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26763986
17.
Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions.
Hematol Oncol
; 31(2): 72-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23027689
18.
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE).
Cancers (Basel)
; 15(9)2023 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173908
19.
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma Foundation.
Cancer
; 118(16): 3954-61, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22179904
20.
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification.
Haematologica
; 102(9): e352-e355, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28596282